Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in spinal disorder treatments, has scheduled its Fourth Quarter and Year End 2024 financial results announcement for March 6, 2025, after market close.
The company will host a conference call at 4:30 PM ET on the same day, featuring President and CEO Sean Browne and CFO Scott Neils. Investors can access the call via domestic (888-506-0062) or international (973-528-0011) dial-in numbers using passcode 907938. A webcast will be available, with a replay accessible later on the company's website.
Xtant Medical Holdings (NYSE American: XTNT), un'azienda globale di tecnologia medica specializzata nel trattamento dei disturbi spinali, ha programmato l'annuncio dei risultati finanziari del Quarto Trimestre e Fine Anno 2024 per il 6 marzo 2025, dopo la chiusura del mercato.
L'azienda ospiterà una conferenza telefonica alle 16:30 ET lo stesso giorno, con il Presidente e CEO Sean Browne e il CFO Scott Neils. Gli investitori possono accedere alla chiamata tramite i numeri di accesso nazionali (888-506-0062) o internazionali (973-528-0011) utilizzando il codice di accesso 907938. Sarà disponibile un webcast, con una registrazione accessibile successivamente sul sito web dell'azienda.
Xtant Medical Holdings (NYSE American: XTNT), una empresa global de tecnología médica especializada en tratamientos para trastornos de la columna vertebral, ha programado el anuncio de sus resultados financieros del Cuarto Trimestre y Fin de Año 2024 para el 6 de marzo de 2025, después del cierre del mercado.
La empresa llevará a cabo una llamada de conferencia a las 4:30 PM ET el mismo día, con el Presidente y CEO Sean Browne y el CFO Scott Neils. Los inversores pueden acceder a la llamada a través de los números de marcación nacionales (888-506-0062) o internacionales (973-528-0011) utilizando el código de acceso 907938. Habrá un webcast disponible, con una repetición accesible más tarde en el sitio web de la empresa.
Xtant Medical Holdings (NYSE American: XTNT)는 척추 질환 치료를 전문으로 하는 글로벌 의료 기술 회사로, 2024년 4분기 및 연말 재무 결과 발표를 2025년 3월 6일 시장 종료 후로 예정했습니다.
회사는 같은 날 오후 4시 30분 ET에 회의를 개최하며, 회장 겸 CEO인 Sean Browne와 CFO인 Scott Neils가 참석합니다. 투자자들은 국내 전화(888-506-0062) 또는 국제 전화(973-528-0011)를 통해 907938 비밀번호를 사용하여 통화에 접속할 수 있습니다. 웹캐스트가 제공되며, 나중에 회사 웹사이트에서 재생할 수 있습니다.
Xtant Medical Holdings (NYSE American: XTNT), une entreprise mondiale de technologie médicale spécialisée dans les traitements des troubles de la colonne vertébrale, a programmé l'annonce de ses résultats financiers pour le quatrième trimestre et la fin de l'année 2024 pour le 6 mars 2025, après la clôture du marché.
L'entreprise organisera une conférence téléphonique à 16h30 ET le même jour, avec le Président et CEO Sean Browne et le CFO Scott Neils. Les investisseurs peuvent accéder à l'appel via les numéros de téléphone nationaux (888-506-0062) ou internationaux (973-528-0011) en utilisant le code d'accès 907938. Un webinaire sera disponible, avec une rediffusion accessible plus tard sur le site Web de l'entreprise.
Xtant Medical Holdings (NYSE American: XTNT), ein globales Medizintechnikunternehmen, das sich auf die Behandlung von Wirbelsäulenerkrankungen spezialisiert hat, hat die Bekanntgabe seiner finanziellen Ergebnisse für das 4. Quartal und das Jahresende 2024 für den 6. März 2025 nach Marktschluss angesetzt.
Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz abhalten, an der Präsident und CEO Sean Browne sowie CFO Scott Neils teilnehmen. Investoren können über die nationalen (888-506-0062) oder internationalen (973-528-0011) Einwahlnummern mit dem Zugangscode 907938 an der Konferenz teilnehmen. Ein Webcast wird verfügbar sein, mit einer späteren Wiederholung auf der Website des Unternehmens.
- None.
- None.
BELGRADE, MT / ACCESS Newswire / February 28, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2024, after the close of the financial markets on Thursday, March 6, 2025.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Thursday, March 6, 2025 at 4:30 PM ET to review results.
Conference Details:
Conference Date: Thursday, March 6, 2025
Conference Time: 4:30 PM ET
Conference dial-in: 888-506-0062
International dial-in: 973-528-0011
Passcode: 907938
Conference Call Name: Xtant Medical Q4 and Year End 2024 Financial Results
Webcast Link: https://www.webcaster4.com/Webcast/Page/3039/52116
Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor Info."
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
Brett Maas • Managing Partner, Hayden IR
brett@haydenir.com • (646) 536-7331
SOURCE: Xtant Medical Holdings, Inc.
View the original press release on ACCESS Newswire
FAQ
When will Xtant Medical (XTNT) release its Q4 and full-year 2024 earnings?
How can investors join Xtant Medical's (XTNT) Q4 2024 earnings call?
Who will be presenting at Xtant Medical's (XTNT) Q4 2024 earnings call?
Where can I find the replay of Xtant Medical's (XTNT) Q4 2024 earnings call?
